403
Sorry!!
Error! We're sorry, but the page you were
looking for doesn't exist.
Proteomics Market Size To Reach USD 92.8 Billion By 2033, At 14.7% CAGR: Insights By Dimension Market Research
| Report Highlights | Details |
| Market Size (2024) | USD 27.0 Bn |
| Forecast Value (2033) | USD 92.8 Bn |
| CAGR (2024-2033) | 14.7% |
| Leading Region in terms of Revenue Share | North America |
| Percentage of Revenue Share by Leading Region | 47.3% |
| Historical Data | 2018 - 2023 |
| Forecast Data | 2024 - 2033 |
| Base Year | 2023 |
| Estimate Year | 2024 |
| Segments Covered | By Product, By Technology, By Application, By End User |
| Regional Coverage | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
Market Analysis
Reagents and consumables are projected to dominate the proteomics market, holding 69.1% of the market share in 2024, with growth expected through 2033 Such factors include a better and well-developed life sciences market, health care sector, availability of sufficient funding, and high prevalence of diseases.
Some of the players are Thermo Fisher Scientific and Agilent Technologies which are very instrumental in spearheading new technologies. The region enjoys a strong academia-industry nexus, support from the governing bodies at the country level through the FDA, and early access to next-gen technologies that strengthen North America's status as the leading region for proteomics market.
Growth Drivers
- Rising Incidence of Chronic Diseases: The growing incidence of diseases of modern civilization like cancer and diabetes is driving proteomics to garner better insights into the ailments and to create treatment strategies as per the same. Proteomics helps in the molecular diagnosis of diseases and the generation of disease diagnostic markers and therapeutic targets. Increased Research Funding: Many governments, private companies as well as research foundations offer significant funding to proteomics research and development; new tools are being developed while research is very active. Such efforts, as in the Human Proteome Project, are becoming very essential for the study of the human body and diseases.
Restraints
- High Costs: Proteomics instruments and technologies are costly, making them to be out of reach for many investigators including those in developing countries or small laboratories. The operational and maintenance costs escalate, and it requires skilled individuals to manage the machinery, adding to the overall cost. Complex Data Analysis: Proteomics data is not all-encompassing or simple and it calls for sophisticated techniques and bioinformatics to analyze and compare it with other biological data. One of the major issues is that there are no specific procedures for working with Big Data and the system's inability to integrate with others, with other data platforms.
Growth Opportunities
- Expansion in Emerging Markets: In emerging markets, proteomics is expected to provide good market growth with increasing healthcare costs and better infrastructure in Asia-Pacific, Latin America, and Middle East regions. These regions are considered potential grounds for companies working in the field of proteomics to expand the size of their market share. Personalized Medicine: The growth of market demand increases due to growing awareness of biomarkers as proteomics gives essential information for developing the appropriate therapies. This methodology decreases adverse effects and increases the efficacy of the treatment options since they are determined by the person's genotype.
Purchase the Competition Analysis Dashboard Today:
Proteomics Market Segmentation
By Product
- Reagents & Consumables
- Antibodies and Antigens Buffers and Solvents Enzymes Kits and Assays
- Mass Spectrometers Chromatography Systems Microarray Instruments Electrophoresis Systems Spectroscopy Instruments
- Protein Identification and Characterization Quantitative Proteomics Post-translational Modifications (PTMs) Analysis Bioinformatics Analysis
By Technology
- Spectroscopy
- Mass Spectrometry NMR Spectroscopy CD Spectroscopy
- HPLC Chromatography Ion Chromatography Affinity Chromatography Superficial Chromatography
- Gel Electrophoresis Capillary Electrophoresis
By Application
- Clinical Diagnostics
- Biomarker Discovery and Validation Diagnostic Assays Personalized Medicine
- Target Identification and Validation Lead Compound Screening Mechanism of Action Studies Toxicology Studies
By End User
- Hospitals Clinical Laboratories Pharmaceutical & Biotechnology Companies Academic Research Laboratories Other End Users
Discover additional reports tailored to your industry needs
- Next Generation Cancer Diagnostics Market size is expected to reach a value of USD 19.1 billion in 2024, and it is further anticipated to reach a market value of USD 47.2 billion by 2033 at a CAGR of 10.6%.
mHealth Market size is expected to reach a value of USD 75.2 billion in 2024, and it is further anticipated to reach a market value of USD 210.8 billion by 2033 at a CAGR of 12.1%. Pulse Oximeter Market size is expected to hold a market value of USD 2.7 billion in 2024 and is projected to show subsequent growth with a market value of USD 4.9 billion by the end of 2033 at a CAGR of 7.0%. Predictive Disease Analytics Market is expected to reach a value of USD 2.6 billion in 2024, and it is further anticipated to reach a market value of USD 19.2 billion by 2033 at a CAGR of 24.7%. Precision Medicine Market is expected to reach a value of USD 83.9 billion in 2024, and it is further anticipated to reach a market value of USD 225.7 billion by 2033 at a CAGR of 11.6%. Pharmaceutical Intermediates Market size is expected to reach a value of USD 44.9 billion in 2024, and it is further anticipated to reach a market value of USD 90.4 billion by 2033 at a CAGR of 8.1%. Medical Plastic Compound Market is expected to dominate with USD 60.8 billion in 2024 and is anticipated to grow to USD 119.4 billion by 2033 at a CAGR of 7.8%. Personalized Medicine Biomarker Market size is expected to reach a value of USD 17.0 billion in 2024, and it is further anticipated to reach a market value of USD 72.7 billion by 2033 at a CAGR of 17.5%. Nutraceutical Excipients Market size is expected to reach a value of USD 5.2 billion in 2024, and it is further anticipated to reach a market value of USD 10.0 billion by 2033 at a CAGR of 7.6%. Next Generation Sequencing Market size is expected to hold a market value of USD 13.5 billion in 2024 and is projected to show subsequent growth with a market value of USD 92.2 billion by the end of 2033 at a CAGR of 23.8%.
Regional Analysis
North America, is expected to hold 47.3% of the global proteomics market share in 2024 and is projected to grow further through 2033. Such factors include a better and well-developed life sciences market, health care sector, availability of sufficient funding, and high prevalence of diseases.
Some of the players are Thermo Fisher Scientific and Agilent Technologies which are very instrumental in spearheading new technologies. Well-coordinated academic-industry relationships, the backing of the FDA, and first-mover advantage to new instruments and products also support North America's position in proteomics market.
By Region
North America
- The U.S. Canada
Europe
- Germany The U.K. France Italy Russia Spain Benelux Nordic Rest of Europe
Asia-Pacific
- China Japan South Korea India ANZ ASEAN Rest of Asia-Pacific
Latin America
- Brazil Mexico Argentina Colombia Rest of Latin America
Middle East & Africa
- Saudi Arabia UAE South Africa Israel Egypt Rest of MEA
Click to Request Sample Report and Drive Impactful Decisions:
Recent Developments in the Proteomics Market
- June 2024: Caprion Proteomics Inc launched a new proteomics platform integrating AI for enhanced biomarker discovery and disease diagnostics. May 2024: Thermo Fisher Scientific secured a USD 50 million investment in a public-private partnership aimed at advancing nano proteomics research and development. April 2024: Merck & Co. and academic research laboratories established a major collaboration to accelerate proteomics-based drug discovery and development. March 2024: Agilent Technologies introduced advancements in mass spectrometry, providing more accurate and rapid protein analysis, boosting the market. February 2024: A study by Pfizer highlighted proteomics' role in understanding protein mechanisms in Alzheimer's disease, opening new treatment avenues. January 2024: Bruker Corporation introduced innovative bioinformatics tools designed to streamline data analysis and integration in proteomics research. December 2023: Private funding for proteomics research reached a new high, with venture capital firms investing in start-ups focused on proteomics technologies, including Quantum-Si. November 2023: Bio-Rad Laboratories announced a breakthrough in proteomics, revealing new biomarkers for early cancer detection, showcasing proteomics' potential in clinical outcomes. February 2023: Waters Corporation acquired Wyatt Technology, enhancing their portfolio of separation and detection solutions across various applications. October 2022: Agilent Technologies Inc. and CMP Scientific Corporation entered into a co-marketing agreement to provide an integrated capillary electrophoresis-mass spectrometry solution for the life science and pharmaceutical industries. August 2022: Bruker Corporation launched the nanoElute 2 nano-LC, MetaboScape and TASQ 2023 software for fluxomics, and latest advances in PaSER intelligent acquisition to enhance research in protein-protein interactions (PPIs) and metaproteomics applications.
About Dimension Market Research (DMR)
Dimension Market Research (DMR) is a market research and consulting firm based in India & US, with its headquarters located in the USA (New York). The company believes in providing the best and most valuable data to its customers using the best resources analysts work, to create unmatchable insights into the industries, and markets while offering in-depth results of over 30 industries, and all major regions across the world.
We also believe that our clients don't always want what they see, so we provide customized reports as well, as per their specific requirements to create the best possible outcomes for them and enhance their business through our data and insights in every possible way.
CONTACT: United States 957 Route 33, Suite 12 #308 Hamilton Square, NJ-08690 Phone No.: +1 732 369 9777, +91 88267 74855 ...
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.
Comments
No comment